{"sourcedb":"DevicePMAs@therightstef","sourceid":"P180050_S000","text":"Approval for The BAROSTIM NEO System.  The device is indicated for the improvement of symptoms of heart failure. quality of life, six-minute hall walk and functional status, for patients who remain symptomatic despite treatment with guideline-directed medical therapy, are NYHA Class III or Class II (who had a recent history of Class III), have a left ventricular ejection fraction \u003C= 35%, a NT-proBNP \u003C 1600 pg/ml and excluding patients indicated for Cardiac Resynchronization Therapy (CRT) according to AHA/ACC/ESC guidelines.","project":"consensus_PMA_Age_Indications"}